SEC Form 4 · accession 0001209191-16-156605
Dolby Laboratories, Inc. · DLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin J Yeaman
Officer — President and CEO · Director
Period of report
Dec 21, 2016
Accepted (ET)
Dec 22, 2016 · 7:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001308547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF2 | Dec 21, 2016 | F | 7,136 | $46.30 | D | 118,251 | D | |
| Class A Common StockF3 | Dec 22, 2016 | S | 2,943 | $46.098 | D | 132,895 | I | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| Class A Common Stock | holding | — | — | — | 135,838 | I | By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incident to the vesting of restricted stock units.
- F2Shares held following the reported transactions include 118,251 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
- F3This transaction was executed in multiple trades at prices ranging from $45.95 to $46.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Remarks
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.